148 related articles for article (PubMed ID: 34382590)
1. Oral opening training increases oral opening in patients with oral submucous fibrosis.
Chen J; Wu Y; Peng J; Ma L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):731-735. PubMed ID: 34382590
[TBL] [Abstract][Full Text] [Related]
2. Comparison between Efficacy of Combined Use of Hyaluronidise and Triamcinolone versus Hyaluronidise, Triamcinolone Acetonide and Oral Colchicine in the Treatment of Oral Submucous Fibrosis.
Mostafa MG; Khan JA; Ahmed S; Kamruzzaman M; Islam MR; Rahman MA; Alam MM; Khan L
Mymensingh Med J; 2021 Jan; 30(1):79-84. PubMed ID: 33397855
[TBL] [Abstract][Full Text] [Related]
3. [Expression of secreted frizzled-related protein-1 in patient with oral submucous fibrosis].
Lyu FY; Wang HF; Xu CJ; Xu Z; Li DM; Chi YT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2016 Oct; 51(10):616-622. PubMed ID: 27719707
[No Abstract] [Full Text] [Related]
4. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function.
Lin HJ; Lin JC
Oral Dis; 2007 Jul; 13(4):407-13. PubMed ID: 17577328
[TBL] [Abstract][Full Text] [Related]
5. [Methods and effects of injection of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis].
Xiao YC; Jian XC; Zheng L; Zhou C; DU YX
Shanghai Kou Qiang Yi Xue; 2017 Apr; 26(2):188-192. PubMed ID: 28815250
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis.
Jiang XW; Zhang Y; Yang SK; Zhang H; Lu K; Sun GL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):339-44. PubMed ID: 23260769
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effectiveness of salvianolic acid B and triamcinolone acetonide in treatment of oral submucous fibrosis].
Jian XC; Zheng L; Zhu R; Wang BP; Zhou T; Du YX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jan; 52(1):16-21. PubMed ID: 28072989
[No Abstract] [Full Text] [Related]
8. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis.
Cox S; Zoellner H
J Oral Pathol Med; 2009 Feb; 38(2):220-6. PubMed ID: 18673417
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Efficacy of Topical Curcumin Gel with Triamcinolone-hyaluronidase Gel Individually and in Combination in the Treatment of Oral Submucous Fibrosis.
Lanjekar AB; Bhowate RR; Bakhle S; Narayane A; Pawar V; Gandagule R
J Contemp Dent Pract; 2020 Jan; 21(1):83-90. PubMed ID: 32381807
[TBL] [Abstract][Full Text] [Related]
10. Mouth-opening device as a treatment modality in trismus patients with head and neck cancer and oral submucous fibrosis: a prospective study.
Li YH; Chang WC; Chiang TE; Lin CS; Chen YW
Clin Oral Investig; 2019 Jan; 23(1):469-476. PubMed ID: 29696422
[TBL] [Abstract][Full Text] [Related]
11. Allicin as a possible adjunctive therapeutic drug for stage II oral submucous fibrosis: a preliminary clinical trial in a Chinese cohort.
Jiang X; Zhang Y; Li F; Zhu Y; Chen Y; Yang S; Sun G
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1540-6. PubMed ID: 26165773
[TBL] [Abstract][Full Text] [Related]
12. Oral submucous fibrosis: A clinicopathological study of 674 cases in China.
Cai X; Yao Z; Liu G; Cui L; Li H; Huang J
J Oral Pathol Med; 2019 Apr; 48(4):321-325. PubMed ID: 30715767
[TBL] [Abstract][Full Text] [Related]
13. Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis.
Tilakaratne WM; Ekanayaka RP; Herath M; Jayasinghe RD; Sitheeque M; Amarasinghe H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):224-31. PubMed ID: 27422421
[TBL] [Abstract][Full Text] [Related]
14. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
Vedeswari CP; Jayachandran S; Ganesan S
Indian J Dent Res; 2009; 20(3):261-7. PubMed ID: 19884705
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis].
Wu Y; Peng J; Que G; Xu C; Yin X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):358-64. PubMed ID: 20448359
[TBL] [Abstract][Full Text] [Related]
16. Iatrogenic cushing's syndrome post intralesional triamcinolone acetonide in oral submucous fibrosis: 2 case reports.
Choden K; Gyeltshen T
BMC Oral Health; 2023 Oct; 23(1):813. PubMed ID: 37898806
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Lycopene in the Treatment of Oral Submucous Fibrosis: A Meta-analysis of Randomized Controlled Trials.
Guo J; Xie H; Wu H; Liang M
J Evid Based Dent Pract; 2020 Dec; 20(4):101471. PubMed ID: 33303091
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis.
Daga D; Singh RK; Pal US; Gurung T; Gangwar S
Natl J Maxillofac Surg; 2017; 8(1):50-54. PubMed ID: 28761276
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy for combined injection of salvizanolic acid B with triamcinolone acetonide on the treatment of the soft palate with oral submucous fibrosis].
Lu C; Jian X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):801-804. PubMed ID: 31413219
[TBL] [Abstract][Full Text] [Related]
20. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.
Saran G; Umapathy D; Misra N; Channaiah SG; Singh P; Srivastava S; Shivakumar S
Indian J Dent Res; 2018; 29(3):303-312. PubMed ID: 29900913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
